tiprankstipranks
Advertisement

BBSC - ETF AI Analysis

Compare

Top Page

BBSC

JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC)

Rating:63Neutral
Price Target:
BBSC, the JPMorgan BetaBuilders U.S. Small Cap Equity ETF, has a solid overall rating that reflects a mix of promising growth stories and some higher-risk names in its small-cap portfolio. Strong contributors like Krystal Biotech, Moog, DigitalOcean, and JFrog support the fund’s quality through robust growth, positive earnings updates, and strategic initiatives, especially in areas like aerospace, software, and AI. However, weaker holdings such as TeraWulf, with financial instability and bearish trading signals, along with other companies facing high leverage or profitability challenges, add risk, and the fund’s focus on smaller U.S. companies means investors should be comfortable with higher volatility and sector-specific swings.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of the returns generated by the portfolio.
Broad Sector Diversification
Holdings are spread across many sectors, including technology, health care, financials, and industrials, which helps reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Focus
Almost all of the ETF’s assets are invested in U.S. companies, offering very limited international diversification.
Small-Cap Volatility Risk
Because the fund targets smaller companies, its share price can be more sensitive to market swings and economic downturns.
Concentration in Top Sectors
A large portion of the portfolio is concentrated in technology, health care, and financials, which could hurt performance if these areas weaken.

BBSC vs. SPDR S&P 500 ETF (SPY)

BBSC Summary

JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) is an ETF that follows the Morningstar US Small Cap Target Market Exposure Extended Index, focusing on smaller U.S. companies with room to grow. It holds hundreds of stocks across many sectors, including technology, health care, and financials. Some recognizable names in the fund are Semtech and DigitalOcean Holdings. Investors might consider BBSC to add diversification and long-term growth potential from smaller, more innovative businesses. A key risk is that small-cap stocks can be more volatile than larger companies, so the value of this ETF can go up and down sharply with the market.
How much will it cost me?The JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s passively managed, aiming to track an index rather than actively selecting stocks.
What would affect this ETF?The BBSC ETF, focused on U.S. small-cap stocks, could benefit from economic growth and innovation within sectors like technology, health care, and industrials, as smaller companies often thrive during periods of expansion. However, it may face challenges from rising interest rates, which can increase borrowing costs for small-cap firms, and economic slowdowns that disproportionately impact smaller businesses. Additionally, sector-specific risks, such as regulatory changes in health care or energy, could influence performance.

BBSC Top 10 Holdings

BBSC leans into U.S. small caps, with tech and health care names quietly steering the ship. DigitalOcean and FormFactor are among the rising stars, riding enthusiasm around cloud and chip testing to give the fund some extra lift. Semtech has also been climbing, helped by improving sentiment in semiconductors. On the flip side, crypto‑linked players like TeraWulf and Riot Platforms are more volatile passengers, sometimes jolting returns rather than steadily pulling their weight. Overall, the ETF is broadly diversified across U.S. sectors, but with a noticeable tilt toward smaller tech and innovation-driven companies.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
1.08%$7.58M
Semtech0.49%$3.46M$12.76B164.00%
69
Neutral
Moog0.44%$3.10M$12.77B120.42%
73
Outperform
American Healthcare REIT, Inc.0.42%$2.97M$11.91B48.92%
64
Neutral
Arrowhead Pharmaceuticals0.42%$2.97M$12.49B433.70%
57
Neutral
DigitalOcean Holdings0.42%$2.92M$16.68B356.33%
73
Outperform
BrightSpring Health Services, Inc.0.41%$2.86M$13.69B238.04%
67
Neutral
CareTrust REIT0.36%$2.50M$10.01B35.48%
80
Outperform
Corcept Therapeutics0.35%$2.43M$9.76B43.01%
76
Outperform
Formfactor0.34%$2.41M$8.84B229.29%
68
Neutral

BBSC Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
87.77
Positive
100DMA
83.27
Positive
200DMA
79.54
Positive
Market Momentum
MACD
0.52
Positive
RSI
48.82
Neutral
STOCH
48.12
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBSC, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 90.36, equal to the 50-day MA of 87.77, and equal to the 200-day MA of 79.54, indicating a neutral trend. The MACD of 0.52 indicates Positive momentum. The RSI at 48.82 is Neutral, neither overbought nor oversold. The STOCH value of 48.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BBSC.

BBSC Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$703.00M0.09%
63
Neutral
$880.42M0.48%
72
Outperform
$720.50M0.38%
67
Neutral
$717.14M0.42%
68
Neutral
$696.42M0.40%
70
Neutral
$640.39M0.49%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
89.13
20.85
30.54%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
EES
WisdomTree U.S. SmallCap Fund
JHSC
John Hancock Multifactor Small Cap ETF
SMDV
ProShares Russell 2000 Dividend Growers ETF
SFLO
VictoryShares Small Cap Free Cash Flow ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement